跳至主要内容
临床试验/NCT05484544
NCT05484544已完成不适用

Safety and Efficacy of Hs-cTnT Protocols

Region Skane0 个研究点目标入组 1,167 人开始时间: 2013年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Region Skane
入组人数
1,167
主要终点
30-day MACE

研究概览

简要总结

Chest pain is a common presenting complaint among patients in the emergency department (ED). A large portion of patients with chest pain undergo lengthy assessment in the ED or are admitted to rule out acute oronary syndrome (ACS), often with stress testing, creating a substantial health care burden. The new high-sensitivity cardiac troponin assays allow use of shorter time intervals for repeated blood samples and may improve care for chest pain patients. The aim of this cohort is to evaluate high-sentivity troponin based protocols for ruling out and ruling in ACS in the ED.

详细描述

This is a prospective observational study conducted at Skåne University Hospital (Lund, Sweden). Patients presenting with non-traumatic chest pain and for whom hs-cTnT testing was ordered at presentation will be enrolled between february 2013 to April 2014 after providing written informed consent. Patients with STEMI during index visit and those with severe communication barriers will not be enrolled. Enrolled patients will have a second blood sample for hs-cTnT analyzed 1 h after the first sample. Patients with hemolysis with a hemoglobin concentration >0.1 g/dl, H-index >=100 in either the 0- or

1-h sample will be excluded. Clinical data and 1-h high sensitivity troponin T samples will be collected by research assistants. Further diagnostic testing and treatment will be performed, as in routine care, at the discretion of the responsible physician.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >=18 years of age
  • Presented to the ED with non-traumatic chest pain/discomfort
  • Hs-cTnT testing was ordered at presentation

排除标准

  • STEMI at presentation
  • Severe communication barriers
  • Hemolysis with a hemoglobin concentration>0.1 g/dl, H-index>=100

结局指标

主要结局

30-day MACE

时间窗: 30 days

MACE within 30 days including the index visit. MACE was defined as an adjudicated diagnosis of AMI, UA, cardiac arrest, cardiogenic shock, ventricular arrhythmia requiring intervention, atrioventricular block requiring intervention, or death of a cardiac or unknown cause

次要结局

  • 30-day MACE without UA(30 days)

研究者

发起方
Region Skane
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ulf Ekelund

Professor

Region Skane

相似试验